Search Results - "Averbukh, L A"

Refine Results
  1. 1

    Development of bruneomycin and rubomycin resistance in mouse lymphadenosis tumor cells and Staphyloccus when these preparations are used separately or together by Averbukh, L A

    Published in Antibiotiki (01-12-1977)
    “…Two sublines of mouse lymphadenosis (L-5178) resistant to bruneomycin and rubomycin used alone, as well as a subline with induced resistance to the combination…”
    Get more information
    Journal Article
  2. 2

    Study using the probit-analysis method of the process of increasing resistance to dipin and bruneomycin in Fisher L-5178 lymphadenosis cells in experiments on animals by Averbukh, L A

    Published in Antibiotiki (01-02-1976)
    “…The study of the process of resistance induction in the cells of lymphadenosis to dipin (subline L-5178/D) and bruneomycin (subline L-5178/B) showed that with…”
    Get more information
    Journal Article
  3. 3

    Development of resistance in Fisher lymphadenosis cells to dipin and bruneomycin when these preparations are used separately and in combination by Averbukh, L A

    Published in Antibiotiki (01-04-1975)
    “…It was shown that dipin and bruneomycin resistant tumor cells appeared in mice with transplanted lymphadenosis after 10 passages on single use of the drugs…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Cross resistance in tumor cells and staphylococci with respect to anthracycline-group antineoplastic antibiotics by Shorin, V A, Averbukh, L A

    Published in Antibiotiki (01-10-1976)
    “…The variants of the tumor cells of Fisher lymphadenosis, strain L-5178 and Staph. aureus resistant to rubomycin simultaneously became partially less sensitive…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8

    Antitumor activity of the components of a carminomycin complex by Shorin, V A, Bazhanov, V S, Averbukh, L A

    Published in Antibiotiki (01-01-1977)
    “…The antiblastomic activity of the carminomycin complex components was studied with respect to 8 strains of transplantable tumors of mice: lymphosarcoma L10-1,…”
    Get more information
    Journal Article
  9. 9

    Antitumor activity of carminomycin antibiotic used orally by Shorin, V A, Bazhanov, V S, Averbukh, L A

    Published in Antibiotiki (01-11-1976)
    “…Antitumor activity of karminomycin used perorally was studied with respect to 3 strains of mouse transplantable tumors, i. e. one ascitic strain of…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Synthesis and antitumor properties of carminomycin 13-cyclohexylidenhydrazone by Povarov, L S, Bazhanov, V S, Averbukh, L A, Gol'dberg, L E, Tarasova, V E

    Published in Antibiotiki (01-02-1983)
    “…Carminomycin 13-cyclohexylidenhydrazone (CCH) was prepared by interaction of carminomycin 13-hydrazone with cyclohexane. The antiblastomic properties of CCH…”
    Get more information
    Journal Article
  15. 15

    Synthesis of rubomycin 13-tert-butoxycarbonylhydrazone and the study of its antitumor action by Povarov, L S, Gol'dberg, L E, Bazhanov, V S, Olsuf'eva, E N, Averbukh, L A

    Published in Antibiotiki (01-11-1981)
    “…13-Tert-butoxycarbonylhydrazone of rubomycin was prepared on interaction of rubomycin with tert-butoxycarbonylhydrazine. The new compound showed a high…”
    Get more information
    Journal Article
  16. 16

    Effect of microbial and tumor cell adaptation to rubomycin on their uptake of rubomycin and carminomycin by Ostanina, L N, Averbukh, L A, Karpov, V L, Dudnik, Iu V, Liashenko, V A

    Published in Antibiotiki (01-09-1978)
    “…Anthracycline antibiotics rubomycin (daunomycin) and carminomycin rapidly accumulated in the bacterial and ascitic tumor cells and their intracellular…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20